BJDX
Bluejay Diagnostics, Inc.
Latest Form 4:Purchase$97KbyHRT FINANCIAL LP (10% Owner) · filed Jul 13, 2026
Bluejay Diagnostics, Inc. (BJDX) has 7 SEC Form 4 filings (8 transaction rows) in the rolling window, disclosed by 6 distinct insiders. Most recent filing: Aug 18, 2026.
Insiders have net bought $173K over the trailing 6 months.
- Industry:Medical - Devices
- CEO:Indranil Dey
- Employees:6
- HQ:Acton, MA, US
- IPO:2021-11-10
Insider Buying
$222K
reported purchases (SEC code P)
Insider Selling
$49K
reported sales (SEC code S)
Unique Insiders
6
in the rolling window
Market Cap
$4.0M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| 10% Owner | Purchase | 64,047 | $97K | Jul 13 | SEC ↗ | |
| 10% Owner | Sale | 34,938 | $49K | Jul 13 | SEC ↗ | |
Dey IndranilFirst filing | President and CEO | Purchase | 12,500 | $25K | May 18 | SEC ↗ |
CHASE DONALD RFirst filing | Director | Purchase | 12,500 | $25K | May 18 | SEC ↗ |
Wurth Douglas ClarkFirst filing | Director | Purchase | 12,500 | $25K | May 18 | SEC ↗ |
Dey SvetlanaFirst filing | Director | Purchase | 12,500 | $25K | May 18 | SEC ↗ |
ZEIDMAN FRED SFirst filing | Director | Purchase | 12,500 | $25K | May 18 | SEC ↗ |
Related companies
Bluejay Diagnostics, Inc. is in the Healthcare sector.